Olanzapine Patent Expiration
Olanzapine is Used for treating treatment-resistant depression in adults. It was first introduced by Cheplapharm Registration Gmbh
Olanzapine Patents
Given below is the list of patents protecting Olanzapine, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Zyprexa | US6960577 | Combination therapy for treatment of refractory depression |
Nov 01, 2017
(Expired) | Cheplapharm |
| Zyprexa Zydis | US6960577 | Combination therapy for treatment of refractory depression |
Nov 01, 2017
(Expired) | Cheplapharm |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Olanzapine's patents.
Latest Legal Activities on Olanzapine's Patents
Given below is the list recent legal activities going on the following patents of Olanzapine.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Patent Issue Date Used in PTA Calculation Critical | 01 Nov, 2005 | US6960577 |
| Recordation of Patent Grant Mailed Critical | 01 Nov, 2005 | US6960577 |
| Issue Notification Mailed Critical | 12 Oct, 2005 | US6960577 |
| Receipt into Pubs | 06 Oct, 2005 | US6960577 |
| Dispatch to FDC | 05 Oct, 2005 | US6960577 |
| Application Is Considered Ready for Issue Critical | 13 Aug, 2005 | US6960577 |
| Issue Fee Payment Verified Critical | 05 Jul, 2005 | US6960577 |
| Issue Fee Payment Received Critical | 05 Jul, 2005 | US6960577 |
| Mail Examiner's Amendment | 02 Jun, 2005 | US6960577 |
| Mail Notice of Allowance Critical | 02 Jun, 2005 | US6960577 |
Olanzapine's Family Patents
Explore Our Curated Drug Screens
Olanzapine Generic API Manufacturers
Several generic applications have been filed for Olanzapine. The first generic version for Olanzapine was by Strides Pharma Global Pte Ltd and was approved on Oct 24, 2011. And the latest generic version is by Aspiro Pharma Ltd and was approved on Mar 22, 2023.
Given below is the list of companies who have filed for Olanzapine generic, along with the locations of their manufacturing plants worldwide.
1. AJANTA PHARMA LTD
Ajanta Pharma Ltd has filed for 6 different strengths of generic version for Olanzapine. Given below are the details of the strengths of this generic introduced by Ajanta Pharma Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 7.5MG | tablet | Discontinued | ORAL | N/A | Aug 30, 2016 |
| 10MG | tablet, orally disintegrating | Discontinued | ORAL | N/A | May 30, 2017 |
| 15MG | tablet, orally disintegrating | Discontinued | ORAL | N/A | May 30, 2017 |
| 20MG | tablet, orally disintegrating | Discontinued | ORAL | N/A | May 30, 2017 |
| 5MG | tablet, orally disintegrating | Discontinued | ORAL | N/A | May 30, 2017 |
| 2.5MG | tablet | Discontinued | ORAL | N/A | Aug 30, 2016 |
Manufacturing Plant Locations New
Ajanta Pharma Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Ajanta Pharma Ltd as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| India |
| |||
2. ALKEM LABS LTD
Alkem Laboratories Ltd has filed for 6 different strengths of generic version for Olanzapine. Given below are the details of the strengths of this generic introduced by Alkem Labs Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5MG | tablet | Prescription | ORAL | AB | Oct 20, 2015 |
| 2.5MG | tablet | Prescription | ORAL | AB | Oct 20, 2015 |
| 7.5MG | tablet | Prescription | ORAL | AB | Oct 20, 2015 |
| 10MG | tablet | Prescription | ORAL | AB | Oct 20, 2015 |
| 15MG | tablet | Prescription | ORAL | AB | Oct 20, 2015 |
| 20MG | tablet | Prescription | ORAL | AB | Oct 20, 2015 |
3. AM REGENT
American Regent Inc has filed for 1 generic for Olanzapine. Given below are the details of the strengths of this generic introduced by Am Regent.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10MG/VIAL | injectable | Prescription | INTRAMUSCULAR | AP | Mar 20, 2012 |
4. APOTEX INC
Apotex Inc has filed for 6 different strengths of generic version for Olanzapine. Given below are the details of the strengths of this generic introduced by Apotex Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5MG | tablet | Prescription | ORAL | AB | Apr 23, 2012 |
| 10MG | tablet | Prescription | ORAL | AB | Apr 23, 2012 |
| 15MG | tablet | Prescription | ORAL | AB | Apr 23, 2012 |
| 20MG | tablet | Prescription | ORAL | AB | Apr 23, 2012 |
| 2.5MG | tablet | Prescription | ORAL | AB | Apr 23, 2012 |
| 7.5MG | tablet | Prescription | ORAL | AB | Apr 23, 2012 |
Manufacturing Plant Locations New
Apotex Inc's manufacturing plants are situated in 1 country - Canada. Given below are the details of these plant locations as well as the firm names of Apotex Inc as present at those locations.
| Country | City | Firm Name | ||||||
|---|---|---|---|---|---|---|---|---|
| Canada |
| |||||||
5. ASPIRO
Aspiro Pharma Ltd has filed for 1 generic for Olanzapine. Given below are the details of the strengths of this generic introduced by Aspiro.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10MG/VIAL | injectable | Prescription | INTRAMUSCULAR | AP | Mar 22, 2023 |
Manufacturing Plant Locations New
Aspiro's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Aspiro as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| India |
| |||
6. AUROBINDO PHARMA LTD
Aurobindo Pharma Ltd has filed for 6 different strengths of generic version for Olanzapine. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 2.5MG | tablet | Prescription | ORAL | AB | Apr 23, 2012 |
| 5MG | tablet, orally disintegrating | Prescription | ORAL | AB | May 15, 2014 |
| 7.5MG | tablet | Prescription | ORAL | AB | Apr 23, 2012 |
| 10MG | tablet, orally disintegrating | Prescription | ORAL | AB | May 15, 2014 |
| 15MG | tablet, orally disintegrating | Prescription | ORAL | AB | May 15, 2014 |
| 20MG | tablet, orally disintegrating | Prescription | ORAL | AB | May 15, 2014 |
Manufacturing Plant Locations New
Aurobindo Pharma Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma Ltd as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| India |
| |||
7. BARR LABS INC
Barr Laboratories Inc has filed for 4 different strengths of generic version for Olanzapine. Given below are the details of the strengths of this generic introduced by Barr Labs Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 20MG | tablet, orally disintegrating | Prescription | ORAL | AB | Jan 30, 2012 |
| 5MG | tablet, orally disintegrating | Prescription | ORAL | AB | Jan 30, 2012 |
| 10MG | tablet, orally disintegrating | Prescription | ORAL | AB | Jan 30, 2012 |
| 15MG | tablet, orally disintegrating | Prescription | ORAL | AB | Jan 30, 2012 |
8. CADILA PHARMS LTD
Cadila Pharmaceuticals Ltd has filed for 6 different strengths of generic version for Olanzapine. Given below are the details of the strengths of this generic introduced by Cadila Pharms Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10MG | tablet | Prescription | ORAL | AB | Feb 24, 2023 |
| 15MG | tablet | Prescription | ORAL | AB | Feb 24, 2023 |
| 20MG | tablet | Prescription | ORAL | AB | Feb 24, 2023 |
| 7.5MG | tablet | Prescription | ORAL | AB | Feb 24, 2023 |
| 5MG | tablet | Prescription | ORAL | AB | Feb 24, 2023 |
| 2.5MG | tablet | Prescription | ORAL | AB | Feb 24, 2023 |
9. CHARTWELL MOLECULAR
Chartwell Molecular Holdings Llc has filed for 6 different strengths of generic version for Olanzapine. Given below are the details of the strengths of this generic introduced by Chartwell Molecular.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 2.5MG | tablet | Prescription | ORAL | AB | Mar 15, 2016 |
| 5MG | tablet, orally disintegrating | Prescription | ORAL | AB | Mar 16, 2016 |
| 7.5MG | tablet | Prescription | ORAL | AB | Mar 15, 2016 |
| 10MG | tablet, orally disintegrating | Prescription | ORAL | AB | Mar 16, 2016 |
| 15MG | tablet, orally disintegrating | Prescription | ORAL | AB | Mar 16, 2016 |
| 20MG | tablet, orally disintegrating | Prescription | ORAL | AB | Mar 16, 2016 |
10. DR REDDYS LABS LTD
Dr Reddys Laboratories Ltd has filed for 6 different strengths of generic version for Olanzapine. Given below are the details of the strengths of this generic introduced by Dr Reddys Labs Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 20MG | tablet, orally disintegrating | Prescription | ORAL | AB | Oct 24, 2011 |
| 5MG | tablet | Prescription | ORAL | AB | Apr 23, 2012 |
| 10MG | tablet | Prescription | ORAL | AB | Apr 23, 2012 |
| 15MG | tablet | Prescription | ORAL | AB | Apr 23, 2012 |
| 2.5MG | tablet | Prescription | ORAL | AB | Apr 23, 2012 |
| 7.5MG | tablet | Prescription | ORAL | AB | Apr 23, 2012 |
11. EUGIA PHARMA
Eugia Pharma Specialities Ltd has filed for 1 generic for Olanzapine. Given below are the details of the strengths of this generic introduced by Eugia Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10MG/VIAL | injectable | Prescription | INTRAMUSCULAR | AP | Oct 22, 2020 |
Manufacturing Plant Locations New
Eugia Pharma's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Eugia Pharma as present at those locations.
| Country | City | Firm Name | ||||||
|---|---|---|---|---|---|---|---|---|
| India |
| |||||||
12. HEC PHARM
Hec Pharm Usa Inc has filed for 4 different strengths of generic version for Olanzapine. Given below are the details of the strengths of this generic introduced by Hec Pharm.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 20MG | tablet, orally disintegrating | Prescription | ORAL | AB | Jul 2, 2018 |
| 5MG | tablet, orally disintegrating | Prescription | ORAL | AB | Jul 2, 2018 |
| 10MG | tablet, orally disintegrating | Prescription | ORAL | AB | Jul 2, 2018 |
| 15MG | tablet, orally disintegrating | Prescription | ORAL | AB | Jul 2, 2018 |
Manufacturing Plant Locations New
Hec Pharm's manufacturing plants are situated in 1 country - China. Given below are the details of these plant locations as well as the firm names of Hec Pharm as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| China |
| |||
13. HIKMA
Hikma Pharmaceuticals Llc has filed for 6 different strengths of generic version for Olanzapine. Given below are the details of the strengths of this generic introduced by Hikma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5MG | tablet | Discontinued | ORAL | N/A | Jun 16, 2017 |
| 15MG | tablet | Discontinued | ORAL | N/A | Jun 16, 2017 |
| 20MG | tablet | Discontinued | ORAL | N/A | Jun 16, 2017 |
| 7.5MG | tablet | Discontinued | ORAL | N/A | Jun 16, 2017 |
| 2.5MG | tablet | Discontinued | ORAL | N/A | Jun 16, 2017 |
| 10MG | tablet | Discontinued | ORAL | N/A | Jun 16, 2017 |
Manufacturing Plant Locations New
Hikma's manufacturing plants are situated in 3 countries - United States, Portugal, Jordan. Given below are the details of these plant locations as well as the firm names of Hikma as present at those locations.
| Country | City | Firm Name | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||
| Portugal |
| |||||||||
| Jordan |
| |||||||||
14. HISUN PHARM HANGZHOU
Hisun Pharmaceutical (hangzhou) Co Ltd has filed for 6 different strengths of generic version for Olanzapine. Given below are the details of the strengths of this generic introduced by Hisun Pharm Hangzhou.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 20MG | tablet | Discontinued | ORAL | N/A | Dec 31, 2020 |
| 5MG | tablet | Discontinued | ORAL | N/A | Dec 31, 2020 |
| 10MG | tablet | Discontinued | ORAL | N/A | Dec 31, 2020 |
| 15MG | tablet | Discontinued | ORAL | N/A | Dec 31, 2020 |
| 2.5MG | tablet | Discontinued | ORAL | N/A | Dec 31, 2020 |
| 7.5MG | tablet | Discontinued | ORAL | N/A | Dec 31, 2020 |
15. INDOCO
Indoco Remedies Ltd has filed for 6 different strengths of generic version for Olanzapine. Given below are the details of the strengths of this generic introduced by Indoco.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 2.5MG | tablet | Discontinued | ORAL | N/A | Jul 31, 2020 |
| 20MG | tablet | Discontinued | ORAL | N/A | Jul 31, 2020 |
| 15MG | tablet | Discontinued | ORAL | N/A | Jul 31, 2020 |
| 5MG | tablet | Discontinued | ORAL | N/A | Jul 31, 2020 |
| 7.5MG | tablet | Discontinued | ORAL | N/A | Jul 31, 2020 |
| 10MG | tablet | Discontinued | ORAL | N/A | Jul 31, 2020 |
Manufacturing Plant Locations New
Indoco's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Indoco as present at those locations.
| Country | City | Firm Name | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||
16. IVAX PHARMS INC
Ivax Pharmaceuticals Inc has filed for 1 generic for Olanzapine. Given below are the details of the strengths of this generic introduced by Ivax Pharms Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 20MG | tablet | Discontinued | ORAL | N/A | Apr 29, 2015 |
17. JIANGSU HANSOH PHARM
Jiangsu Hansoh Pharmaceutical Group Co Ltd has filed for 3 different strengths of generic version for Olanzapine. Given below are the details of the strengths of this generic introduced by Jiangsu Hansoh Pharm.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 2.5MG | tablet | Discontinued | ORAL | N/A | Sep 24, 2018 |
| 5MG | tablet | Discontinued | ORAL | N/A | Sep 24, 2018 |
| 10MG | tablet | Discontinued | ORAL | N/A | Sep 24, 2018 |
Manufacturing Plant Locations New
Jiangsu Hansoh Pharm's manufacturing plants are situated in 1 country - China. Given below are the details of these plant locations as well as the firm names of Jiangsu Hansoh Pharm as present at those locations.
| Country | City | Firm Name | ||||
|---|---|---|---|---|---|---|
| China |
| |||||
18. JUBILANT GENERICS
Jubilant Generics Ltd has filed for 4 different strengths of generic version for Olanzapine. Given below are the details of the strengths of this generic introduced by Jubilant Generics.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 20MG | tablet, orally disintegrating | Prescription | ORAL | AB | Sep 12, 2012 |
| 5MG | tablet, orally disintegrating | Prescription | ORAL | AB | Sep 12, 2012 |
| 10MG | tablet, orally disintegrating | Prescription | ORAL | AB | Sep 12, 2012 |
| 15MG | tablet, orally disintegrating | Prescription | ORAL | AB | Sep 12, 2012 |
Manufacturing Plant Locations New
Jubilant Generics's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Jubilant Generics as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| India |
| |||
19. MACLEODS PHARMS LTD
Macleods Pharmaceuticals Ltd has filed for 6 different strengths of generic version for Olanzapine. Given below are the details of the strengths of this generic introduced by Macleods Pharms Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 20MG | tablet, orally disintegrating | Prescription | ORAL | AB | Feb 20, 2015 |
| 2.5MG | tablet | Prescription | ORAL | AB | Aug 15, 2014 |
| 5MG | tablet, orally disintegrating | Prescription | ORAL | AB | Feb 20, 2015 |
| 7.5MG | tablet | Prescription | ORAL | AB | Aug 15, 2014 |
| 10MG | tablet, orally disintegrating | Prescription | ORAL | AB | Feb 20, 2015 |
| 15MG | tablet, orally disintegrating | Prescription | ORAL | AB | Feb 20, 2015 |
20. MYLAN
Mylan Pharmaceuticals Inc has filed for 4 different strengths of generic version for Olanzapine. Given below are the details of the strengths of this generic introduced by Mylan.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 15MG | tablet, orally disintegrating | Prescription | ORAL | AB | May 12, 2014 |
| 5MG | tablet, orally disintegrating | Prescription | ORAL | AB | May 12, 2014 |
| 10MG | tablet, orally disintegrating | Prescription | ORAL | AB | May 12, 2014 |
| 20MG | tablet, orally disintegrating | Prescription | ORAL | AB | May 12, 2014 |
Manufacturing Plant Locations New
Mylan's manufacturing plants are situated in 4 countries - United States, India, Canada, Ireland. Given below are the details of these plant locations as well as the firm names of Mylan as present at those locations.
| Country | City | Firm Name | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||||||
| India |
| |||||||||||||||||
| Canada |
| |||||||||||||||||
| Ireland |
| |||||||||||||||||
21. NATCO PHARMA
Natco Pharma Ltd has filed for 6 different strengths of generic version for Olanzapine. Given below are the details of the strengths of this generic introduced by Natco Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 2.5MG | tablet | Discontinued | ORAL | N/A | Apr 23, 2012 |
| 5MG | tablet | Discontinued | ORAL | N/A | Apr 23, 2012 |
| 7.5MG | tablet | Discontinued | ORAL | N/A | Apr 23, 2012 |
| 10MG | tablet | Discontinued | ORAL | N/A | Apr 23, 2012 |
| 15MG | tablet | Discontinued | ORAL | N/A | Apr 23, 2012 |
| 20MG | tablet | Discontinued | ORAL | N/A | Apr 23, 2012 |
Manufacturing Plant Locations New
Natco Pharma's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Natco Pharma as present at those locations.
| Country | City | Firm Name | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||||||
22. ORBION PHARMS
Orbion Pharmaceuticals Private Ltd has filed for 6 different strengths of generic version for Olanzapine. Given below are the details of the strengths of this generic introduced by Orbion Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 2.5MG | tablet | Prescription | ORAL | AB | Apr 23, 2012 |
| 5MG | tablet, orally disintegrating | Prescription | ORAL | AB | Mar 2, 2015 |
| 7.5MG | tablet | Prescription | ORAL | AB | Apr 23, 2012 |
| 10MG | tablet, orally disintegrating | Prescription | ORAL | AB | Mar 2, 2015 |
| 15MG | tablet, orally disintegrating | Prescription | ORAL | AB | Mar 2, 2015 |
| 20MG | tablet, orally disintegrating | Prescription | ORAL | AB | Mar 2, 2015 |
23. QILU
Qilu Pharmaceutical Co Ltd has filed for 6 different strengths of generic version for Olanzapine. Given below are the details of the strengths of this generic introduced by Qilu.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 20MG | tablet | Prescription | ORAL | AB | Jan 27, 2016 |
| 2.5MG | tablet | Prescription | ORAL | AB | Jan 27, 2016 |
| 15MG | tablet | Prescription | ORAL | AB | Jan 27, 2016 |
| 10MG | tablet | Prescription | ORAL | AB | Jan 27, 2016 |
| 7.5MG | tablet | Prescription | ORAL | AB | Jan 27, 2016 |
| 5MG | tablet | Prescription | ORAL | AB | Jan 27, 2016 |
Manufacturing Plant Locations New
Qilu's manufacturing plants are situated in 1 country - China. Given below are the details of these plant locations as well as the firm names of Qilu as present at those locations.
| Country | City | Firm Name | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| China |
| |||||||||||||||
24. SANDOZ INC
Sandoz Inc has filed for 1 generic for Olanzapine. Given below are the details of the strengths of this generic introduced by Sandoz Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10MG/VIAL | injectable | Prescription | INTRAMUSCULAR | AP | Oct 24, 2011 |
Manufacturing Plant Locations New
Sandoz Inc's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Sandoz Inc as present at those locations.
| Country | City | Firm Name | ||||
|---|---|---|---|---|---|---|
| United States |
| |||||
25. STRIDES PHARMA
Strides Pharma Global Pte Ltd has filed for 4 different strengths of generic version for Olanzapine. Given below are the details of the strengths of this generic introduced by Strides Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5MG | tablet, orally disintegrating | Prescription | ORAL | AB | Oct 24, 2011 |
| 10MG | tablet, orally disintegrating | Prescription | ORAL | AB | Oct 24, 2011 |
| 15MG | tablet, orally disintegrating | Prescription | ORAL | AB | Oct 24, 2011 |
| 20MG | tablet, orally disintegrating | Prescription | ORAL | AB | Oct 24, 2011 |
Manufacturing Plant Locations New
Strides Pharma's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Strides Pharma as present at those locations.
| Country | City | Firm Name | ||||
|---|---|---|---|---|---|---|
| United States |
| |||||
| India |
| |||||
26. SUN PHARM INDS
Sun Pharmaceutical Industries Ltd has filed for 6 different strengths of generic version for Olanzapine. Given below are the details of the strengths of this generic introduced by Sun Pharm Inds.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 15MG | tablet | Discontinued | ORAL | N/A | Apr 23, 2012 |
| 10MG | tablet | Discontinued | ORAL | N/A | Apr 23, 2012 |
| 5MG | tablet | Discontinued | ORAL | N/A | Apr 23, 2012 |
| 20MG | tablet | Discontinued | ORAL | N/A | Apr 23, 2012 |
| 2.5MG | tablet | Discontinued | ORAL | N/A | Apr 23, 2012 |
| 7.5MG | tablet | Discontinued | ORAL | N/A | Apr 23, 2012 |
27. SUNSHINE
Sunshine Lake Pharma Co Ltd has filed for 6 different strengths of generic version for Olanzapine. Given below are the details of the strengths of this generic introduced by Sunshine.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10MG | tablet | Discontinued | ORAL | N/A | Nov 19, 2018 |
| 15MG | tablet | Discontinued | ORAL | N/A | Nov 19, 2018 |
| 2.5MG | tablet | Discontinued | ORAL | N/A | Nov 19, 2018 |
| 5MG | tablet | Discontinued | ORAL | N/A | Nov 19, 2018 |
| 20MG | tablet | Discontinued | ORAL | N/A | Nov 19, 2018 |
| 7.5MG | tablet | Discontinued | ORAL | N/A | Nov 19, 2018 |
Manufacturing Plant Locations New
Sunshine's manufacturing plants are situated in 6 countries - United States, Peru, India, Thailand, China, Mozambique. Given below are the details of these plant locations as well as the firm names of Sunshine as present at those locations.
| Country | City | Firm Name | ||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||||||||||||||||||||||||||||||
| Peru |
| |||||||||||||||||||||||||||||||||||||||||
| India |
| |||||||||||||||||||||||||||||||||||||||||
| Thailand |
| |||||||||||||||||||||||||||||||||||||||||
| China |
| |||||||||||||||||||||||||||||||||||||||||
| Mozambique |
| |||||||||||||||||||||||||||||||||||||||||
28. TEVA PHARMS
Teva Pharmaceuticals Usa has filed for 5 different strengths of generic version for Olanzapine. Given below are the details of the strengths of this generic introduced by Teva Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5MG | tablet | Discontinued | ORAL | N/A | Oct 24, 2011 |
| 7.5MG | tablet | Discontinued | ORAL | N/A | Oct 24, 2011 |
| 10MG | tablet | Discontinued | ORAL | N/A | Oct 24, 2011 |
| 15MG | tablet | Discontinued | ORAL | N/A | Oct 24, 2011 |
| 2.5MG | tablet | Discontinued | ORAL | N/A | Oct 24, 2011 |
29. TORRENT
Torrent Pharmaceuticals Ltd has filed for 4 different strengths of generic version for Olanzapine. Given below are the details of the strengths of this generic introduced by Torrent.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 15MG | tablet, orally disintegrating | Prescription | ORAL | AB | Oct 25, 2011 |
| 10MG | tablet, orally disintegrating | Prescription | ORAL | AB | Oct 25, 2011 |
| 5MG | tablet, orally disintegrating | Prescription | ORAL | AB | Oct 25, 2011 |
| 20MG | tablet, orally disintegrating | Prescription | ORAL | AB | Oct 25, 2011 |
Manufacturing Plant Locations New
Torrent's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Torrent as present at those locations.
| Country | City | Firm Name | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||||
| United States |
| |||||||||||
30. TORRENT PHARMS LTD
Torrent Pharmaceuticals Ltd has filed for 6 different strengths of generic version for Olanzapine. Given below are the details of the strengths of this generic introduced by Torrent Pharms Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10MG | tablet | Discontinued | ORAL | N/A | Apr 23, 2012 |
| 2.5MG | tablet | Discontinued | ORAL | N/A | Apr 23, 2012 |
| 5MG | tablet | Discontinued | ORAL | N/A | Apr 23, 2012 |
| 7.5MG | tablet | Discontinued | ORAL | N/A | Apr 23, 2012 |
| 15MG | tablet | Discontinued | ORAL | N/A | Apr 23, 2012 |
| 20MG | tablet | Discontinued | ORAL | N/A | Apr 23, 2012 |
31. ZYDUS PHARMS
Zydus Pharmaceuticals Usa Inc has filed for 6 different strengths of generic version for Olanzapine. Given below are the details of the strengths of this generic introduced by Zydus Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 2.5MG | tablet | Prescription | ORAL | AB | Jul 16, 2018 |
| 5MG | tablet, orally disintegrating | Discontinued | ORAL | N/A | Mar 9, 2023 |
| 20MG | tablet, orally disintegrating | Discontinued | ORAL | N/A | Mar 9, 2023 |
| 15MG | tablet, orally disintegrating | Discontinued | ORAL | N/A | Mar 9, 2023 |
| 10MG | tablet, orally disintegrating | Discontinued | ORAL | N/A | Mar 9, 2023 |
| 7.5MG | tablet | Prescription | ORAL | AB | Jul 16, 2018 |